News

By Jonah Comstock April 25, 2017
Remote clinical trial company Science 37 has raised $29 million in a round led by Glynn Capital Management with participation from Google's investment arm GV. One more new investor -- AmGen ventures -- contributed, as did existing investors Lux Capital, Redmile Group, dRx Capital, and Sanofi Ventures. It's a large round with impressive investors, but it is technically a down round from last fall'...
By Jonah Comstock April 25, 2017
An Illinois-based law firm has filed a class action lawsuit against telemedicine company MDLive, alleging that the company takes screenshots of sensitive patient health information and sends them to TestFairy, an Israeli company that does quality control on apps, and that this is a violation of patient privacy. MDLive, for its part, denies that there's anything improper about its procedures. The...
By Heather Mack April 25, 2017
The most visible and utilized telemedicine tools available today are mainly geared toward primary care, but there is a growing emergence of specialty and high-touch medicine delivered through telemedicine technology. Case in point, Royal Philips debuted its enterprise-level telemedicine software designed for use in intensive care units at the American Telemedicine Conference in Orlando. Philips’...
By Jonah Comstock April 25, 2017
UK-based health chatbot company babylon, which raised $25 million in early 2016, has raised an additional $60 million in funding. While the company didn't disclose the investors, TechCrunch and Financial Times report that the round included Sawiris, an Egyptian billionaire business family, NNS holdings, Vostok New Ventures, and existing backers Kinnevik. They also report that the company's total...
By Heather Mack April 25, 2017
Santa Cruz, California-based Two Pore Guys, which is developing a novel method of diagnostic testing via a device that digitally detects molecules, has raised $24.5 million in Series A funding in a round led by Khosla Ventures. Two Pore Guys (aka 2PG) will use the funding to scale up the manufacturing of their hand-held device, which works like a glucose monitor, albeit with disposable test...
By Jonah Comstock April 25, 2017
Seattle-based healthcare quality transparency company Mpirica has raised $4.6 million in a round led by equity crowdfunding platform OurCrowd. An undisclosed Seattle-based private equity fund also contributed to the round. The company plans to use the funsing to support a national rollout to Medicare Advantage customers. With its team of data scientists and physicians, Mpirica uses claims data to...
By Jonah Comstock April 25, 2017
Cincinnati, Ohio-based clinical communications provider Doc Halo has raised $11 million in a series A round led by Bane Capital Ventures. Cincinnati-based Refinery Ventures also contributed to the round. Doc Halo has been operating for seven years in the clinical comms space, but this is its first outside funding round; cofounders Dr. Jose Barreau and Dr. Amit Gupta, both former practicing...
By Heather Mack April 24, 2017
Recovering from addiction is more than simply staying away from substances. Along with the myriad challenges of everyday life that could trigger relapses, many people going through addiction treatment also deal with anxiety that can make it even harder for them stay substance-free. That’s why MAP Health Management – the Austin, Texas-based remote monitoring and patient engagement company focused...
By Jonah Comstock April 24, 2017
Medidata, a New York City-based company that offers cloud storage and data analytics services for clinical trials, announced last week its plans to acquire Mytrus, a clinical trial technology company focused on patient-focused electronic informed consent and remote trials. The terms of the acquisition were not disclosed. “The informed consent process is one of the most important parts of running...
By Heather Mack April 24, 2017
Out of the 422 million people around the world living with diabetes, one in three of them will develop diabetic retinopathy (DR), a common condition that can lead to permanent blindness if left untreated. While early detection and treatment can dramatically reduce that risk, a third of people with diabetes have never even been screened for DR, as many are living in low-income, medically...

Editor's Pick